J. Blokken PhD, PharmD

New haematology reimbursements in Belgium

OVERVIEW OF BELGIAN REIMBURSEMENT NEWS

(BELG J HEMATOL 2025;16(2):81)

Advances in Laboratory Technology – Precision medicine and drug response profiling

For the “Advances in Laboratory Technology” session, the BHS invited Prof. Giovanni Roti (University of Parma, Italy) to share his expertise on precision medicine and drug response profiling.

New haematology reimbursements in Belgium

OVERVIEW OF BELGIAN REIMBURSEMENT NEWS

(BELG J HEMATOL 2025;16(1):47)

New haematology reimbursements in Belgium

OVERVIEW OF BELGIAN REIMBURSEMENT NEWS

(BELG J HEMATOL 2024;15(8):333–4)

New haematology reimbursements in Belgium

OVERVIEW OF BELGIAN REIMBURSEMENT NEWS

(BELG J HEMATOL 2024;15(7):302)

New haematology reimbursements in Belgium

OVERVIEW OF BELGIAN REIMBURSEMENT NEWS

(BELG J HEMATOL 2024;15(6):257)

Highlights in myeloid malignancies

SUMMARY

Myeloid malignancies encompass a group of haematopoietic disorders including acute myeloid leukaemia (AML), myeloproliferative neoplasms, and myelodysplastic syndrome (MDS). At EHA 2024, the most recent updates in the area of myeloid malignancies were presented.

(BELG J HEMATOL 2024;15(5):205–10)